Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
UBS
QuintilesIMS
Express Scripts
Queensland Health
Covington
Chubb
Chinese Patent Office
Daiichi Sankyo

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,692,763

« Back to Dashboard

Summary for Patent: 6,692,763
Title: Methods for treating postmenopausal women using ultra-low doses of estrogen
Abstract:The present invention provides methods for treating physical conditions resulting from postmenopausel estrogen decline in a postmenopausel subject, and in particular methods for reducing the risk of osteoporotic bone fractures in a postmenopausal subject. The present invention also provides a kit for carrying out the methods of the present invention.
Inventor(s): Cummings; Steven R. (Mill Valley, CA), Ettinger; Bruce (San Francisco, CA), Ellman; Herman (Mountain Lakes, NJ)
Assignee: The Regents of the University of California (Oakland, CA) Kaiser Foundation Health Plan, Inc. (Oakland, CA) The Permanente Medical Group, Inc. (Oakland, CA) Berlex Laboratories, Inc. (Richmond, CA)
Application Number:09/554,789
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;

Drugs Protected by US Patent 6,692,763

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,692,763

PCT Information
PCT FiledNovember 21, 1998PCT Application Number:PCT/US98/24677
PCT Publication Date:June 03, 1999PCT Publication Number: WO99/26631

International Family Members for US Patent 6,692,763

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Norway 20002587 ➤ Try a Free Trial
South Korea 100576568 ➤ Try a Free Trial
South Korea 20010032257 ➤ Try a Free Trial
Japan 2004083599 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
US Army
Cipla
QuintilesIMS
Federal Trade Commission
Covington
Fuji
Queensland Health
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.